Treatment of nonsense mutation-mediated Duchenne muscular dystrophy in pediatric patients

摘要

Provided is a method for ameliorating or managing nonsense mutation mediated Duchenne muscular dystrophy (nmDMD) in a pediatric patient in need thereof, comprising administering to the patient an effective amount of atalurene.